Best practice at Eli Lilly: The secret to a successful alliance management process

Abstract

Purpose

The paper aims to review the latest management developments across the globe and pinpoints practical implications from cutting‐edge research and case studies.

Design/methodology/approach

This briefing is prepared by an independent writer who adds their own impartial comments and places the articles in context.

Findings

Eli Lilly and Company is a global pharmaceutical company and one of the world's largest corporations. Following a major strategic review during the 1990s, Eli senior executives chose to focus on developing strong organic growth rather than expanding through mergers and acquisitions.

Practical implications

The paper provides strategic insights and practical thinking that have influenced some of the world's leading organizations.

Originality/value

The briefing saves busy executives and researchers hours of reading time by selecting only the very best, most pertinent information and presenting it in a condensed and easy‐to‐digest format.

Citation

(2007), "Best practice at Eli Lilly: The secret to a successful alliance management process", Strategic Direction, Vol. 23 No. 2, pp. 22-24. https://doi.org/10.1108/02580540710724465